Undetectable Post-treatment PSA following 3DCRT or IMRT Alone for Patients with Low or Intermediate Risk Prostate Cancer is an Independent Predictor of Biochemical and Clinical Outcome 51st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) Horwitz, E. M., Ruth, K. J., Sharma, N. K., Chen, D. Y., Buyyounouski, M. K., Uzzo, R. G. ELSEVIER SCIENCE INC. 2009: S301–S301

View details for Web of Science ID 000270573601135